Audrey Thevenon serves as Executive at Bionik Laboratories Corp., where they oversee executive responsibilities. Since joining the company, Audrey Thevenon has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 29, 2021 involved purchasing 26,430 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 29, 2021 | BNKL | $0 | Purchase | 26,430 | $N/A | Discretionary |
Audrey Thevenon currently holds 26,430 shares of Bionik Laboratories Corp. (BNKL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Audrey Thevenon has been a net neutral trader of BNKL stock. They have purchased $0 and sold $0 worth of shares.
Audrey Thevenon's most recent insider trade was on Mar 29, 2021, when they purchased 26,430 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted